Botanix Pharmaceuticals Limited's market cap is currently ―. The company's EPS TTM is AU$-0.007; its P/E ratio is -28.77; Botanix Pharmaceuticals Limited is scheduled to report earnings on August 22, 2024, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 7.29M	AU$ 21.55M	AU$ 24.65M	AU$ 4.70M	AU$ 17.26M
Total Assets	AU$ 14.04M	AU$ 21.95M	AU$ 25.31M	AU$ 5.20M	AU$ 17.71M
Total Debt	AU$ 122.41K	AU$ 259.32K	AU$ 420.62K	AU$ 0.00	AU$ 0.00
Net Debt	AU$ -7.16M	AU$ -21.30M	AU$ -24.22M	AU$ -4.70M	AU$ -17.26M
Total Liabilities	AU$ 5.89M	AU$ 1.15M	AU$ 1.67M	AU$ 4.58M	AU$ 1.43M
Stockholders Equity	AU$ 8.15M	AU$ 20.80M	AU$ 23.64M	AU$ 615.22K	AU$ 16.28M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in AUD

Botanix Pharmaceuticals Limited Earnings and Revenue History

Income Statement >

Botanix Pharmaceuticals Limited Debt to Assets

Balance Sheet >

Botanix Pharmaceuticals Limited Cash Flow

Cash Flow >

Botanix Pharmaceuticals Limited Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing